13 patients with SAPHO syndrome with nail lesions and palmoplantar pustulosis were treated wtih tofacitinib with significant improvement in nail scores (58-77%), psoriasis scores, QOL, DQLI and acute phase reactants. https://t.co/J8yB4pRHS1